^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

tipapkinogene sovacivec (TG4001)

i
Other names: TG4001, TG-4001, MVA-HPV-IL2, RG3484, RO5217790, MVA virus vector encoding HPV types 16 E6 and E7 antigens and IL-2 adjuvant, RG 3484, RG-3484, RO 5217790, RO-5217790, TG 4001, R3484, R 3484, R-3484
Associations
Trials
Company:
European Organization for Research and Treatment of Cancer, Transgene
Drug class:
IL-2 stimulant, HPV-16 E6 protein inhibitor, HPV-16 E7 protein inhibitor
Related drugs:
Associations
Trials